Hims & Hers Health, Inc.
HIMSHims & Hers Health, Inc. in brief
Hims & Hers Health, Inc. is a listed company in the FMCG industry, based in San Francisco, California, USA. It was founded in 2017. Its market value was $7.0 B on 30 October 2026, which makes it the 2,840th largest listed company in the world and the 869th largest in the USA on this site. In the year to December 2025 it had sales of $2.3 B and a net profit of $128 M, about 5 cents of profit for every dollar of sales. It employs about 398 people and Andrew Dudum is its chief executive. By market, the largest shares of its 2025 sales came from USA (94%). Its shares trade under the symbol HIMS (NYSE).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model.
From Wikipedia: read the full article · text available under CC BY-SA 4.0
Hims & Hers Health, Inc. timeline
- 2017
- 🏁· approximateFounded
- 2019
- 🔔· approximateInitial public offering on NYSE
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- •Legal Entity Identifier issuedLEI 549300ZQ4ZUYSAAX6P59 registered.
- 2021
- ✎Renamed Hims & Hers Health, Inc.Formerly Oaktree Acquisition Corp..
- 2024
- 💰Revenue passed $1 billionFY2024 revenue of $1.5 billion, up from $872 million in FY2023.
- 2025
- 💰Record revenue of $2.3 billionFY2025, the highest of the 7 years on record.
Events of Hims & Hers Health, Inc. from Wikidata, the company record, SEC EDGAR, the GLEIF LEI register and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #2,389 (Jan 2022) · #1,730 (Dec 2022) · #1,683 (Jul 2023) · #1,584 (Jan 2024) · #936 (Aug 2026) · #853 (Oct 2026) · #870 (Oct 2026)
Key ratios
- P/E ratio (TTM)
- n/m (loss)
- Price / sales (TTM)
- 2.4×
- Price / book
- 12.9×
- Free cash flow yield
- 0.8%
- Net margin (TTM)
- -6.7%
- Operating margin
- 4.5%
- Return on equity
- -35.3%
- Liabilities / assets
- 74.9%
- Revenue growth
- +59.0%
- Revenue per employee
- $5.9 M
- Profit per employee
- $323 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $2.3B | +59.0% | $106M | $128M | 5.5% |
| Dec 2024 | $1.5B | +69.3% | $62M | $126M | 8.5% |
| Dec 2023 | $872M | +65.5% | $-29M | $-24M | -2.7% |
| Dec 2022 | $527M | +93.8% | $-69M | $-66M | -12.5% |
| Dec 2021 | $272M | +82.8% | $-115M | $-108M | -39.6% |
| Dec 2020 | $149M | +80.2% | $-15M | $-18M | -12.2% |
| Dec 2019 | $83M | — | $-74M | $-72M | -87.3% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $300M | $243M | $57M | $0.51 | — |
| Dec 2024 | $251M | $53M | $198M | $0.53 | — |
| Dec 2023 | $73M | $27M | $47M | $-0.11 | — |
| Dec 2022 | $-27M | $7M | $-34M | $-0.32 | — |
| Dec 2021 | $-34M | — | — | $-0.58 | — |
| Dec 2020 | $-2M | — | — | $-0.51 | — |
| Dec 2019 | $-75M | — | — | $-2.07 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $890M (+48.6% on a year earlier), net income $-33M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.
Annual and quarterly reports
Hims & Hers Health, Inc.'s reports from the last 8 years, from the official filing system. Downloads (Excel financial statements, PDF, the report as filed, or everything as a ZIP) are for Premium subscribers — sign in.
Annual · 7
- Dec 31, 202510-KAnnual reportExcelReportZIP
- Dec 31, 202410-KAnnual reportExcelReportZIP
- Dec 31, 202310-KAnnual reportExcelReportZIP
- Dec 31, 202210-KAnnual reportExcelReportZIP
- Dec 31, 202110-KAnnual reportExcelReportZIP
- Dec 31, 202010-KAnnual reportExcelReportZIP
- Dec 31, 201910-KAnnual reportExcelReportZIP
Quarterly · 22
- Jun 30, 202610-QQuarterly reportExcelReportZIP
- Mar 31, 202610-QQuarterly reportExcelReportZIP
- Sep 30, 202510-QQuarterly reportExcelReportZIP
- Jun 30, 202510-QQuarterly reportExcelReportZIP
- Mar 31, 202510-QQuarterly reportExcelReportZIP
- Sep 30, 202410-QQuarterly reportExcelReportZIP
- Jun 30, 202410-QQuarterly reportExcelReportZIP
- Mar 31, 202410-QQuarterly reportExcelReportZIP
- Sep 30, 202310-QQuarterly reportExcelReportZIP
- Jun 30, 202310-QQuarterly reportExcelReportZIP
- Mar 31, 202310-QQuarterly reportExcelReportZIP
- Sep 30, 202210-QQuarterly reportExcelReportZIP
- Jun 30, 202210-QQuarterly reportExcelReportZIP
- Mar 31, 202210-QQuarterly reportExcelReportZIP
- Sep 30, 202110-QQuarterly reportExcelReportZIP
- Jun 30, 202110-QQuarterly reportExcelReportZIP
- Mar 31, 202110-QQuarterly reportExcelReportZIP
- Sep 30, 202010-QQuarterly reportExcelReportZIP
- Jun 30, 202010-QQuarterly reportExcelReportZIP
- Mar 31, 202010-QQuarterly reportExcelReportZIP
- Sep 30, 201910-QQuarterly reportExcelReportZIP
- Jun 30, 201910-QQuarterly reportExcelReportZIP
SEC filings
- Nov 9, 202610-QQuarterly report · period to Sep 2026
- Nov 9, 20268-KCurrent reportDirectors or officers changed
- Nov 9, 20268-KCurrent reportResults of operations · Other events
- Oct 7, 20268-KCurrent reportDirectors or officers changed
- Aug 10, 202610-QQuarterly report · period to Jun 2026
- Aug 10, 20268-KCurrent reportResults of operations
- Jul 17, 20268-KCurrent reportDirectors or officers changed
- Jul 1, 20268-KCurrent reportMaterial agreement · New financial obligation
- Jun 15, 20268-KCurrent reportShareholder vote
- Jun 2, 20268-KCurrent reportMaterial agreement · New financial obligation · Other events
- May 21, 20268-KCurrent reportMaterial agreement · New financial obligation · Unregistered share sale
- May 19, 20268-KCurrent reportOther events
Official filings of Hims & Hers Health, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $2.3 B
- Operating income
- $106 M
- Net income
- $128 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $2.2 B
- Total liabilities
- $1.6 B
- Total equity
- $541 M
As of December-2025
Top 100 institutional investors in Hims & Hers Health, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 29,739,760 | +1,036,246 (+3.61%) | 12.69% | $886 M | Nov 13, 2026 |
| 2 | Vanguard Portfolio Management LLC | 10,409,131 | -150,183 (-1.42%) | 4.44% | $310 M | Nov 13, 2026 |
| 3 | Vanguard Capital Management LLC | 9,526,404 | -14,980 (-0.16%) | 4.06% | $284 M | Nov 13, 2026 |
| 4 | State Street Corp | 8,239,957 | +94,258 (+1.16%) | 3.52% | $245 M | Nov 12, 2026 |
| 5 | Divisadero Street Capital Management, LP | 7,344,028 | +1,334,523 (+22.21%) | 3.13% | $219 M | Nov 16, 2026 |
| 6 | Morgan Stanley | 6,239,020 | -913,478 (-12.77%) | 2.66% | $186 M | Nov 13, 2026 |
| 7 | Geode Capital Management, LLC | 5,630,567 | -51,265 (-0.90%) | 2.40% | $168 M | Nov 6, 2026 |
| 8 | UBS Group AG | 4,753,288 | +2,092,478 (+78.64%) | 2.03% | $142 M | Nov 10, 2026 |
| 9 | Jpmorgan Chase & Co | 4,752,356 | -14,425 (-0.30%) | 2.03% | $142 M | Nov 12, 2026 |
| 10 | FMR LLC | 4,675,376 | +352,084 (+8.14%) | 1.99% | $139 M | Nov 10, 2026 |
| 11 | Two Sigma Investments, LP | 4,369,652 | New | 1.86% | $130 M | Nov 16, 2026 |
| 12 | Goldman Sachs Group Inc | 3,880,161 | -1,293,704 (-25.00%) | 1.66% | $116 M | Nov 16, 2026 |
| 13 | Charles Schwab Investment Management Inc | 2,630,138 | +176,351 (+7.19%) | 1.12% | $78 M | Nov 16, 2026 |
| 14 | Northern Trust Corp | 2,558,097 | -36,180 (-1.39%) | 1.09% | $76 M | Nov 16, 2026 |
| 15 | BNP Paribas Financial Markets | 2,205,447 | +1,883,003 (+583.98%) | 0.94% | $66 M | Nov 12, 2026 |
| 16 | Price T Rowe Associates Inc /MD/ | 1,653,330 | +721,110 (+77.35%) | 0.71% | $49 M | Nov 16, 2026 |
| 17 | Vanguard Fiduciary Trust Co | 1,518,964 | -3,285 (-0.22%) | 0.65% | $45 M | Nov 13, 2026 |
| 18 | Bank of New York Mellon Corp | 1,340,979 | +7,833 (+0.59%) | 0.57% | $40 M | Nov 5, 2026 |
| 19 | Bank Of America Corp /de/ | 1,270,640 | -1,041,632 (-45.05%) | 0.54% | $38 M | Nov 16, 2026 |
| 20 | Quadrature Capital Ltd | 1,209,178 | +1,121,961 (+1286.40%) | 0.52% | $36 M | Nov 13, 2026 |
| 21 | State Of Michigan Retirement System | 1,207,782 | -1,138,500 (-48.52%) | 0.52% | $36 M | Oct 27, 2026 |
| 22 | Corient Private Wealth LP | 1,188,290 | +1,165,563 (+5128.54%) | 0.51% | $35 M | Nov 16, 2026 |
| 23 | Barclays PLC | 1,102,127 | +241,121 (+28.00%) | 0.47% | $33 M | Nov 6, 2026 |
| 24 | Schroder Investment Management Group | 1,088,864 | -40,917 (-3.62%) | 0.46% | $32 M | Nov 16, 2026 |
| 25 | Franklin Templeton Inc | 1,053,960 | +21,321 (+2.06%) | 0.45% | $31 M | Nov 12, 2026 |
Show all 100: investors 26 to 100
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | Bienville Capital Management, LLC | 974,672 | +188,933 (+24.05%) | 0.42% | $29 M | Nov 16, 2026 |
| 27 | Dimensional Fund Advisors LP | 914,688 | +369,045 (+67.63%) | 0.39% | $27 M | Nov 4, 2026 |
| 28 | Foresite Capital Management V, LLC | 883,751 | +145,600 (+19.72%) | 0.38% | $26 M | Nov 16, 2026 |
| 29 | DekaBank Deutsche Girozentrale | 857,000 | New | 0.37% | $26 M | Oct 27, 2026 |
| 30 | Susquehanna International Group, LLP | 820,085 | +791,135 (+2732.76%) | 0.35% | $24 M | Nov 16, 2026 |
| 31 | Walleye Capital LLC | 804,793 | +779,915 (+3134.96%) | 0.34% | $24 M | Nov 13, 2026 |
| 32 | Casdin Capital, LLC | 800,000 | +100,000 (+14.29%) | 0.34% | $24 M | Nov 16, 2026 |
| 33 | Baillie Gifford & Co | 794,827 | +44,336 (+5.91%) | 0.34% | $24 M | Nov 9, 2026 |
| 34 | Citigroup Inc | 794,544 | +572,243 (+257.42%) | 0.34% | $24 M | Nov 4, 2026 |
| 35 | Principal Financial Group Inc | 788,568 | -878,505 (-52.70%) | 0.34% | $23 M | Nov 2, 2026 |
| 36 | Nuveen, LLC | 721,523 | -62,071 (-7.92%) | 0.31% | $21 M | Nov 10, 2026 |
| 37 | Rhumbline Advisers | 631,254 | -2,524 (-0.40%) | 0.27% | $19 M | Nov 10, 2026 |
| 38 | Kingdon Capital Management, L.L.C. | 624,278 | +81,778 (+15.07%) | 0.27% | $19 M | Nov 16, 2026 |
| 39 | Capital World Investors | 606,726 | New | 0.26% | $18 M | Nov 12, 2026 |
| 40 | Squarepoint Ops LLC | 565,069 | -52,239 (-8.46%) | 0.24% | $17 M | Nov 9, 2026 |
| 41 | National Bank Of Canada /fi/ | 517,246 | -319,709 (-38.20%) | 0.22% | $15 M | Nov 16, 2026 |
| 42 | Jane Street Group, LLC | 493,244 | -507,240 (-50.70%) | 0.21% | $15 M | Nov 12, 2026 |
| 43 | Citadel Advisors LLC | 479,984 | -366,952 (-43.33%) | 0.20% | $14 M | Nov 16, 2026 |
| 44 | Marex Group Ltd | 466,327 | -507,444 (-52.11%) | 0.20% | $14 M | Nov 16, 2026 |
| 45 | Wells Fargo & Company/mn | 456,430 | -102,959 (-18.41%) | 0.19% | $14 M | Nov 16, 2026 |
| 46 | Wellington Management Group LLP | 447,512 | +134,049 (+42.76%) | 0.19% | $13 M | Nov 16, 2026 |
| 47 | CI Investments Inc. | 439,976 | +161,972 (+58.26%) | 0.19% | $13 M | Nov 12, 2026 |
| 48 | HSBC Holdings PLC | 435,603 | -196,805 (-31.12%) | 0.19% | $13 M | Nov 16, 2026 |
| 49 | Clear Street Group Inc. | 430,957 | -558,956 (-56.47%) | 0.18% | $13 M | Nov 16, 2026 |
| 50 | Voloridge Investment Management, LLC | 429,730 | New | 0.18% | $13 M | Nov 16, 2026 |
| 51 | X-Square Capital, LLC | 427,133 | +1,614 (+0.38%) | 0.18% | $13 M | Nov 10, 2026 |
| 52 | Alliancebernstein L.P. | 426,488 | -12,375 (-2.82%) | 0.18% | $13 M | Nov 16, 2026 |
| 53 | Metavasi Capital LP | 422,267 | -124,162 (-22.72%) | 0.18% | $13 M | Nov 16, 2026 |
| 54 | Invesco Ltd. | 421,406 | -123,078 (-22.60%) | 0.18% | $13 M | Nov 12, 2026 |
| 55 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 410,950 | -15,027 (-3.53%) | 0.18% | $12 M | Nov 16, 2026 |
| 56 | Swiss National Bank | 405,900 | +9,300 (+2.34%) | 0.17% | $12 M | Nov 12, 2026 |
| 57 | Tudor Investment Corp Et Al | 396,003 | +267,207 (+207.47%) | 0.17% | $12 M | Nov 16, 2026 |
| 58 | Greenfield Seitz Capital Management, LLC | 385,366 | +17,027 (+4.62%) | 0.16% | $11 M | Oct 29, 2026 |
| 59 | Group One Trading LLC | 354,381 | +26,263 (+8.00%) | 0.15% | $11 M | Nov 10, 2026 |
| 60 | NZS Capital, LLC | 347,780 | New | 0.15% | $10 M | Nov 13, 2026 |
| 61 | Jain Global LLC | 344,487 | -231,373 (-40.18%) | 0.15% | $10 M | Nov 16, 2026 |
| 62 | Kelly Lawrence W & Associates Inc/ca | 330,825 | -1,450 (-0.44%) | 0.14% | $10 M | Nov 16, 2026 |
| 63 | Raymond James Financial Inc | 328,724 | -51,367 (-13.51%) | 0.14% | $10 M | Nov 12, 2026 |
| 64 | Cantor Fitzgerald, L. P. | 313,806 | -793,570 (-71.66%) | 0.13% | $9 M | Nov 16, 2026 |
| 65 | LMR Partners LLP | 286,345 | New | 0.12% | $9 M | Nov 16, 2026 |
| 66 | Commonwealth Equity Services, LLC | 283,323 | -54,365 (-16.10%) | 0.12% | $8 M | Nov 2, 2026 |
| 67 | Legal & General Group Plc | 268,339 | +6,675 (+2.55%) | 0.11% | $8 M | Nov 16, 2026 |
| 68 | Bank Of Montreal /can/ | 262,811 | -513,653 (-66.15%) | 0.11% | $8 M | Nov 9, 2026 |
| 69 | Qube Research & Technologies Ltd | 256,224 | New | 0.11% | $8 M | Nov 13, 2026 |
| 70 | Deutsche Bank AG\ | 252,261 | -179 (-0.07%) | 0.11% | $8 M | Nov 6, 2026 |
| 71 | Ameriprise Financial Inc | 249,590 | -14,114 (-5.35%) | 0.11% | $7 M | Nov 16, 2026 |
| 72 | Hohimer Wealth Management, LLC | 249,130 | -120 (-0.05%) | 0.11% | $7 M | Nov 4, 2026 |
| 73 | Wolverine Asset Management LLC | 241,161 | -10,458 (-4.16%) | 0.10% | $7 M | Nov 2, 2026 |
| 74 | First Trust Advisors LP | 239,624 | +188,615 (+369.77%) | 0.10% | $7 M | Nov 12, 2026 |
| 75 | Creative Planning | 238,305 | +13,099 (+5.82%) | 0.10% | $7 M | Nov 2, 2026 |
| 76 | California State Teachers Retirement System | 231,754 | +1,005 (+0.44%) | 0.10% | $7 M | Nov 13, 2026 |
| 77 | Nomura Asset Management International Inc. | 227,543 | -2,038 (-0.89%) | 0.10% | $7 M | Nov 16, 2026 |
| 78 | QV Investors Inc. | 224,130 | 0 (0.00%) | 0.10% | $7 M | Oct 20, 2026 |
| 79 | California Public Employees Retirement System | 219,972 | -55,907 (-20.27%) | 0.09% | $7 M | Nov 16, 2026 |
| 80 | MetLife Investment Management, LLC | 218,945 | -5,517 (-2.46%) | 0.09% | $7 M | Nov 16, 2026 |
| 81 | Retirement Systems of Alabama | 218,089 | -1,102 (-0.50%) | 0.09% | $6 M | Nov 4, 2026 |
| 82 | LPL Financial LLC | 216,631 | -42,036 (-16.25%) | 0.09% | $6 M | Nov 6, 2026 |
| 83 | Trexquant Investment LP | 212,458 | -20,733 (-8.89%) | 0.09% | $6 M | Nov 16, 2026 |
| 84 | VANGUARD ASSET MANAGEMENT, Ltd | 208,239 | +11,379 (+5.78%) | 0.09% | $6 M | Nov 13, 2026 |
| 85 | Manufacturers Life Insurance Company, The | 205,184 | +10,347 (+5.31%) | 0.09% | $6 M | Nov 13, 2026 |
| 86 | Schonfeld Strategic Advisors LLC | 200,579 | New | 0.09% | $6 M | Nov 16, 2026 |
| 87 | AQR Capital Management LLC | 197,788 | -12,296 (-5.85%) | 0.08% | $6 M | Nov 16, 2026 |
| 88 | Royal Bank Of Canada | 192,855 | -72,334 (-27.28%) | 0.08% | $6 M | Nov 16, 2026 |
| 89 | Neuberger Berman Group LLC | 189,467 | +719 (+0.38%) | 0.08% | $6 M | Nov 13, 2026 |
| 90 | FirstWave Capital Management LLC | 181,277 | -158,701 (-46.68%) | 0.08% | $5 M | Nov 16, 2026 |
| 91 | Jump Financial, LLC | 179,547 | -59,206 (-24.80%) | 0.08% | $5 M | Nov 13, 2026 |
| 92 | Lake Street Private Wealth, LLC | 179,206 | +1,858 (+1.05%) | 0.08% | $5 M | Oct 22, 2026 |
| 93 | New York State Teachers Retirement System | 172,900 | -1,801 (-1.03%) | 0.07% | $5 M | Oct 22, 2026 |
| 94 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 164,502 | +1,846 (+1.13%) | 0.07% | $5 M | Nov 16, 2026 |
| 95 | Davidson Kempner Capital Management LP | 160,012 | 0 (0.00%) | 0.07% | $5 M | Nov 16, 2026 |
| 96 | Gilder Gagnon Howe & Co LLC | 150,979 | +17,058 (+12.74%) | 0.06% | $4 M | Nov 16, 2026 |
| 97 | Kornitzer Capital Management Inc /KS | 142,740 | +26,885 (+23.21%) | 0.06% | $4 M | Nov 3, 2026 |
| 98 | Verition Fund Management LLC | 138,792 | +41,429 (+42.55%) | 0.06% | $4 M | Nov 13, 2026 |
| 99 | Connor, Clark & Lunn Investment Management Ltd. | 133,006 | New | 0.06% | $4 M | Nov 10, 2026 |
| 100 | Millennium Management LLC | 132,943 | New | 0.06% | $4 M | Nov 16, 2026 |
Mutual funds holding Hims & Hers Health, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 iShares Core S&P Mid-Cap ETFBlackRock Fund Advisors | 7.25 M | $251 M | 3.1% | 0.20% | +5.2% | Jun 30, 2026 |
| 🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc. | 6.72 M | $233 M | 2.8% | 0.01% | +1.1% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors | 5.55 M | $192 M | 2.3% | 0.23% | +11% | Jun 30, 2026 |
| 🇺🇸 Vanguard Small-Cap Index FundThe Vanguard Group, Inc. | 4.86 M | $169 M | 2.1% | 0.09% | +1.1% | Jun 30, 2026 |
| 🇺🇸 Vanguard Small-Cap Growth Index FundThe Vanguard Group, Inc. | 2.80 M | $97 M | 1.2% | 0.21% | +4.2% | Jun 30, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 2.43 M | $84 M | 1.0% | 0.09% | +4.8% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors | 2.00 M | $69 M | 0.84% | 0.45% | +19% | Jun 30, 2026 |
| 🇺🇸 JPMorgan Large Cap Growth FundJ.P. Morgan Investment Management Inc. | 1.98 M | $69 M | 0.84% | 0.06% | +0.0% | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC | 2.36 M | $66 M | 1.00% | 0.19% | +16% | Jul 31, 2026 |
| 🇺🇸 State Street SPDR S&P MidCap 400SM ETF TrustSpdr S&P Midcap 400 ETF Trust | 1.63 M | $57 M | 0.69% | 0.20% | +3.9% | Jun 30, 2026 |
| 🇺🇸 iShares S&P Mid-Cap 400 Growth ETFBlackRock Fund Advisors | 1.27 M | $44 M | 0.54% | 0.39% | +0.3% | Jun 30, 2026 |
| 🇺🇸 State Street SPDR Portfolio S&P 400 Mid Cap ETFSSGA Funds Management, Inc. | 1.07 M | $37 M | 0.45% | 0.20% | +5.4% | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Growth FundFidelity Management & Research Company LLC | 1.23 M | $34 M | 0.52% | 0.39% | +186% | Jul 31, 2026 |
| 🇺🇸 Principal U.S. Small-Cap ETFPrincipal Global Investors, LLC | 877,347 | $30 M | 0.37% | 1.3% | +8.7% | Jun 30, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 1.07 M | $28 M | 0.45% | 0.07% | −1.5% | May 31, 2026 |
| 🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc. | 1.05 M | $28 M | 0.45% | 0.16% | +3.7% | May 31, 2026 |
| 🇺🇸 Schwab U.S. Small-Cap ETFCharles Schwab Investment Management, Inc. | 999,147 | $26 M | 0.42% | 0.11% | −1.3% | May 31, 2026 |
| 🇺🇸 Fidelity Small Cap Growth K6 FundFidelity Management & Research Company LLC | 642,260 | $18 M | 0.27% | 0.39% | +194% | Jul 31, 2026 |
| 🇺🇸 Fidelity Stock Selector Small Cap FundFidelity Management & Research Company LLC | 610,700 | $17 M | 0.26% | 0.23% | +208% | Jul 31, 2026 |
| 🇺🇸 Vanguard Health Care Index FundThe Vanguard Group, Inc. | 591,888 | $15 M | 0.25% | 0.08% | +0.6% | May 31, 2026 |
| 🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP | 537,435 | $15 M | 0.23% | 0.08% | no change | Jul 31, 2026 |
| 🇺🇸 T. Rowe Price New Horizons Fund, Inc.T. Rowe Price Associates, Inc. | 429,667 | $15 M | 0.18% | 0.10% | −42% | Jun 30, 2026 |
| 🇺🇸 Schwab U.S. Mid-Cap ETFCharles Schwab Investment Management, Inc. | 563,791 | $15 M | 0.24% | 0.10% | +0.2% | May 31, 2026 |
| 🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc. | 525,151 | $15 M | 0.22% | 0.19% | +17% | Jul 31, 2026 |
| 🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC | 398,449 | $14 M | 0.17% | 0.23% | +20% | Jun 30, 2026 |
| 🇺🇸 iShares U.S. Healthcare Providers ETFBlackRock Fund Advisors | 373,320 | $13 M | 0.16% | 1.1% | +53% | Jun 30, 2026 |
| 🇺🇸 State Street SPDR S & P 400 Mid Cap Growth ETFSSGA Funds Management, Inc. | 327,704 | $11 M | 0.14% | 0.39% | +3.3% | Jun 30, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 393,783 | $10 M | 0.17% | <0.01% | +1.2% | May 31, 2026 |
| 🇺🇸 Franklin Growth Opportunities FundFranklin Advisers, Inc. | 358,810 | $10 M | 0.15% | 0.23% | new | Jul 31, 2026 |
| 🇺🇸 Fidelity Growth Company FundFidelity Management & Research Company LLC | 374,800 | $10 M | 0.16% | <0.01% | new | May 31, 2026 |
| 🇺🇸 BlackRock Advantage Small Cap Core FundBlackRock Advisors, LLC | 372,970 | $10 M | 0.16% | 0.19% | −6.9% | May 29, 2026 |
| 🇺🇸 Fidelity Series Small Cap Opportunities FundFidelity Management & Research Company LLC | 350,600 | $10 M | 0.15% | 0.21% | +151% | Jul 31, 2026 |
| 🇺🇸 iShares Core S&P Total U.S. Stock Market ETFBlackRock Fund Advisors | 275,238 | $10 M | 0.12% | 0.01% | +2.4% | Jun 30, 2026 |
| 🇺🇸 Vanguard S&P Mid-Cap 400 Index FundThe Vanguard Group, Inc. | 332,568 | $9 M | 0.14% | 0.16% | +4.9% | May 31, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 318,978 | $8 M | 0.13% | <0.01% | +3.5% | May 31, 2026 |
| 🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC | 234,449 | $8 M | 0.10% | 0.21% | +9.4% | Jun 30, 2026 |
| 🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC | 281,847 | $8 M | 0.12% | 0.19% | +17% | Jul 31, 2026 |
| 🇺🇸 JNL Mid Cap Index FundJackson National Asset Management, LLC | 213,964 | $7 M | 0.09% | 0.20% | +1.8% | Jun 30, 2026 |
| 🇺🇸 JPMorgan Small Cap Growth FundJ.P. Morgan Investment Management Inc. | 211,101 | $7 M | 0.09% | 0.28% | −5.0% | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC | 202,515 | $7 M | 0.09% | 0.45% | +30% | Jun 30, 2026 |
| 🇺🇸 Optimum Small-Mid Cap Growth FundDelaware Management Company | 199,864 | $7 M | 0.08% | 0.73% | new | Jun 30, 2026 |
| 🇺🇸 Emerald Growth FundRBB Fund, Inc. | 243,554 | $7 M | 0.10% | 0.46% | — | Jul 31, 2026 |
| 🇺🇸 iShares Core S&P U.S. Growth ETFBlackRock Fund Advisors | 179,124 | $6 M | 0.08% | 0.02% | +2.1% | Jun 30, 2026 |
| 🇺🇸 EQ/Mid Cap Index PortfolioEquitable Investment Management Group, LLC | 171,810 | $6 M | 0.07% | 0.20% | +0.6% | Jun 30, 2026 |
| 🇺🇸 Vanguard S&P Mid-Cap 400 Growth Index FundThe Vanguard Group, Inc. | 208,913 | $5 M | 0.09% | 0.30% | +9.9% | May 31, 2026 |
| 🇺🇸 Nuveen ESG Small-Cap ETFNuveen Fund Advisors, LLC | 191,493 | $5 M | 0.08% | 0.41% | −7.5% | Jul 31, 2026 |
| 🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation | 149,500 | $5 M | 0.06% | 0.23% | +9.4% | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc. | 192,292 | $5 M | 0.08% | 0.30% | +2.3% | May 31, 2026 |
| 🇺🇸 Vanguard Total World Stock Index FundThe Vanguard Group, Inc. | 175,475 | $5 M | 0.07% | <0.01% | +9.0% | Jul 31, 2026 |
| 🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC | 173,995 | $5 M | 0.07% | 0.19% | +1245% | Jul 31, 2026 |
| 🇺🇸 Mid Cap Index FundNorthern Trust Investments, Inc. | 137,755 | $5 M | 0.06% | 0.20% | +5.1% | Jun 30, 2026 |
| 🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC | 162,311 | $5 M | 0.07% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Vanguard Explorer FundThe Vanguard Group, Inc. | 161,206 | $4 M | 0.07% | 0.02% | −33% | Jul 31, 2026 |
| 🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC | 128,070 | $4 M | 0.05% | 0.23% | +14% | Jun 30, 2026 |
| 🇺🇸 JPMorgan U.S. Small Company FundJ.P. Morgan Investment Management Inc. | 116,100 | $4 M | 0.05% | 0.36% | +89% | Jun 30, 2026 |
| 🇺🇸 Mid Cap Index FundThe Variable Annuity Life Insurance Company | 153,633 | $4 M | 0.06% | 0.16% | −3.4% | May 31, 2026 |
| 🇺🇸 Buffalo Small Cap Growth FundKornitzer Capital Management, Inc. | 115,855 | $4 M | 0.05% | 0.86% | new | Jun 30, 2026 |
| 🇺🇸 iShares U.S. Small-Cap Equity Factor ETFBlackRock Fund Advisors | 142,128 | $4 M | 0.06% | 0.10% | +2.0% | Jul 31, 2026 |
| 🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc. | 113,390 | $4 M | 0.05% | <0.01% | −3.4% | Jun 30, 2026 |
| 🇺🇸 BlackRock Advantage Small Cap Growth FundBlackRock Funds | 112,355 | $4 M | 0.05% | 0.47% | +15% | Jun 30, 2026 |
| 🇺🇸 Columbia Mid Cap Index FundColumbia Management Investment Advisers, LLC | 148,786 | $4 M | 0.06% | 0.15% | −3.1% | May 31, 2026 |
| 🇺🇸 State Street SPDR S&P Kensho New Economies Composite ETFSSGA Funds Management, Inc. | 111,030 | $4 M | 0.05% | 0.14% | +215% | Jun 30, 2026 |
| 🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc. | 109,346 | $4 M | 0.05% | 0.23% | +16% | Jun 30, 2026 |
| 🇺🇸 Invesco Dorsey Wright Healthcare Momentum ETFInvesco Capital Management LLC | 133,217 | $4 M | 0.06% | 1.6% | new | Jul 31, 2026 |
| 🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc. | 131,448 | $4 M | 0.06% | <0.01% | +7.0% | Jul 31, 2026 |
| 🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc. | 101,478 | $4 M | 0.04% | 0.01% | +2.1% | Jun 30, 2026 |
| 🇺🇸 Index 400 Stock PortfolioMason Street Advisors, LLC | 98,369 | $3 M | 0.04% | 0.20% | +1.5% | Jun 30, 2026 |
| 🇺🇸 JPMorgan Small & Mid Cap Enhanced Equity ETFJ.P. Morgan Investment Management Inc. | 96,618 | $3 M | 0.04% | 0.12% | +4.1% | Jun 30, 2026 |
| 🇺🇸 Empower S&P Mid Cap 400 Index FundEmpower Capital Management, LLC | 96,557 | $3 M | 0.04% | 0.20% | −1.9% | Jun 30, 2026 |
| 🇺🇸 Invesco S&P Midcap 400 Pure Growth ETFInvesco Capital Management LLC | 118,879 | $3 M | 0.05% | 0.98% | −4.8% | Jul 31, 2026 |
| 🇺🇸 Amplify Online Retail ETFAmplify ETF Trust | 94,082 | $3 M | 0.04% | 3.0% | +35% | Jun 30, 2026 |
| 🇺🇸 Schwab U.S. Broad Market ETFCharles Schwab Investment Management, Inc. | 122,203 | $3 M | 0.05% | <0.01% | +1.6% | May 31, 2026 |
| 🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC | 115,061 | $3 M | 0.05% | <0.01% | +6.4% | Jul 31, 2026 |
| 🇺🇸 First Trust Mid Cap Growth AlphaDEX FundFirst Trust Advisors L.P. | 105,897 | $3 M | 0.04% | 0.51% | +221% | Jul 31, 2026 |
| 🇺🇸 JNL/Mellon Healthcare Sector FundJackson National Asset Management, LLC | 83,878 | $3 M | 0.04% | 0.11% | −4.9% | Jun 30, 2026 |
| 🇺🇸 The Hartford Small Company FundHartford Funds Management Company, LLC | 104,355 | $3 M | 0.04% | 0.43% | +63% | Jul 31, 2026 |
| 🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC | 103,472 | $3 M | 0.04% | 0.19% | +16% | Jul 31, 2026 |
| 🇺🇸 State Street SPDR S&P Health Care Services ETFSSGA Funds Management, Inc. | 81,378 | $3 M | 0.03% | 2.0% | — | Jun 30, 2026 |
| 🇺🇸 JPMorgan Active Growth ETFJ.P. Morgan Investment Management Inc. | 80,500 | $3 M | 0.03% | 0.03% | +7.2% | Jun 30, 2026 |
| 🇺🇸 Fidelity Growth Company K6 FundFidelity Management & Research Company LLC | 103,674 | $3 M | 0.04% | <0.01% | new | May 31, 2026 |
| 🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 77,570 | $3 M | 0.03% | 0.12% | +12% | Jun 30, 2026 |
| 🇺🇸 Moa Mid Cap Equity Index FundMUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | 76,221 | $3 M | 0.03% | 0.20% | −2.9% | Jun 30, 2026 |
| 🇺🇸 LVIP Franklin Templeton Multi-Factor SMID Cap Equity FundLincoln Financial Investments Corporation | 75,663 | $3 M | 0.03% | 0.25% | −0.8% | Jun 30, 2026 |
| 🇺🇸 Fidelity MSCI Health Care Index ETFFidelity Management & Research Company LLC | 93,866 | $3 M | 0.04% | 0.08% | +2.9% | Jul 31, 2026 |
| 🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC | 75,170 | $3 M | 0.03% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Fidelity Series Growth Company FundFidelity Management & Research Company LLC | 98,200 | $3 M | 0.04% | 0.01% | new | May 31, 2026 |
| 🇺🇸 Mid Cap Index TrustJohn Hancock Variable Trust Advisers LLC | 73,388 | $3 M | 0.03% | 0.19% | −0.8% | Jun 30, 2026 |
| 🇺🇸 NVIT Mid Cap Index FundNATIONWIDE FUND ADVISORS | 73,181 | $3 M | 0.03% | 0.20% | +4.4% | Jun 30, 2026 |
| 🇺🇸 First Trust Mid Cap Core AlphaDEX FundFirst Trust Advisors L.P. | 89,127 | $2 M | 0.04% | 0.18% | new | Jul 31, 2026 |
| 🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC | 71,361 | $2 M | 0.03% | 0.23% | +10% | Jun 30, 2026 |
| 🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc. | 70,800 | $2 M | 0.03% | 0.08% | +0.6% | Jun 30, 2026 |
| 🇺🇸 JPMorgan BetaBuilders U.S. Mid Cap Equity ETFJ.P. Morgan Investment Management Inc. | 88,303 | $2 M | 0.04% | 0.12% | +7.2% | Jul 31, 2026 |
| 🇺🇸 MetLife Mid Cap Stock Index PortfolioBrighthouse Investment Advisers, LLC | 69,749 | $2 M | 0.03% | 0.20% | −1.3% | Jun 30, 2026 |
| 🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC | 67,748 | $2 M | 0.03% | 0.21% | +11% | Jun 30, 2026 |
| 🇺🇸 JPMorgan Small Cap Blend FundJ.P. Morgan Investment Management Inc. | 67,099 | $2 M | 0.03% | 0.14% | −6.5% | Jun 30, 2026 |
| 🇺🇸 MidCap S&P 400 Index FundPrincipal Global Investors, LLC | 81,023 | $2 M | 0.03% | 0.16% | +1.7% | Jul 31, 2026 |
| 🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC | 78,276 | $2 M | 0.03% | 0.08% | +6.8% | Jul 31, 2026 |
| 🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company | 81,965 | $2 M | 0.03% | 0.16% | −1.5% | May 31, 2026 |
| 🇺🇸 BNY Mellon Midcap Index Fund, Inc.BNY Mellon Investment Adviser, Inc. | 77,104 | $2 M | 0.03% | 0.16% | −8.5% | Jul 31, 2026 |
| 🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC | 60,669 | $2 M | 0.03% | 0.23% | +13% | Jun 30, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Hims & Hers Health, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Deborah M. AutorChief Policy Officer, Director | Sell10b5-1 plan | -23,828 | $18.53 | $442 K | 48,961 | Form 4 |
| filed | Soleil BoughtonChief Legal Officer | Sell10b5-1 plan | -3,458 | $18.53 | $64 K | 311,190 | Form 4 |
| filed | Oluyemi OkupeChief Financial Officer | Sell10b5-1 plan | -3,518 | $18.53 | $65 K | 266,188 | Form 4 |
| filed | Michael ChiChief Operating Officer | Option exercise | +69,769 | — | — | 526,429 | Form 4 |
| filed | Mohamed ElshenawyCTO | Option exercise | +188,286 | — | — | 373,842 | Form 4 |
| filed | Soleil BoughtonChief Legal Officer | Option exercise | +42,262 | — | — | 336,148 | Form 4 |
| filed | Patrick Harrison CarrollChief Medical Officer | Option exercise | +25,927 | — | — | 223,774 | Form 4 |
| filed | David B. WellsDirector | Option exercise | +1,051 | — | — | 230,859 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Hims & Hers Health, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
| Buybacks, quarter | Fiscal | Spent |
|---|---|---|
| Q4 2025 | Q4 2025 | $80.5M |
| Q3 2025 | Q3 2025 | $9.5M |
| Q2 2025 | Q2 2025 | $0M |
| Q1 2025 | Q1 2025 | $0M |
| Q4 2024 | Q4 2024 | $5M |
| Q3 2024 | Q3 2024 | $30M |
| Q2 2024 | Q2 2024 | $19.9M |
| Q1 2024 | Q1 2024 | $28.1M |
| Q4 2023 | Q4 2023 | $2M |
| Q3 2023 | Q3 2024 | $0M |
| Q2 2023 | Q2 2024 | $0M |
| Q1 2023 | Q1 2024 | $0M |
| Q4 2022 | Q4 2022 | $0M |
| Q3 2022 | Q3 2022 | $0M |
| Q2 2022 | Q2 2022 | $0M |
| Q1 2022 | Q1 2022 | $0M |
Fails to deliver
- : 229 shares at $29.67
- : 46,485 shares at $27.71
- : 19,114 shares at $28.15
- : 23,301 shares at $28.07
- : 462 shares at $29.38
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Hims & Hers Health, Inc. scorecard#
Passes 13 of the 23 checks that could be worked out: strongest in financial health (3 of 3), weakest in shareholder returns (0 of 3). Fiscal year 2025; market cap of Oct 30, 2026.
Valuation2 of 6
- ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
- ✗Price to book below its peers' median12.9×Price to book 12.9× against FMCG's median of 5.1×.
- ✓Price to sales below its peers' median2.4×Price to sales 2.4× against FMCG's median of 2.5×.
- ✗Free cash flow yield above 5%0.8%Free cash flow is 0.8% of the market value.
- ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
- ✓The price assumes slower growth than the last three years'25.0%The price assumes 25.0% a year for ten years; revenue grew 64.5% a year over the last three.
Growth5 of 6
- ✓Revenue grew in the newest year59.0%Revenue up 59.0% in fiscal 2025.
- ✓Revenue up more than 5% a year over three years64.5%64.5% a year over the three years to fiscal 2025.
- ✓Faster growth over three years than its peers' median64.5%64.5% a year against FMCG's median of 0.4% (30 companies).
- ✗Earnings per share grew in the newest year0.51 vs 0.53Diluted EPS 0.51 in fiscal 2025 against 0.53 the year before (report's currency).
- ✓Net income higher than five years earlier$128 M$128 M in fiscal 2025 against -$18 M in 2020.
- ✓Revenue rose in at least four of the last five years5 of 5Revenue rose in 5 of the five years to fiscal 2025.
Profitability3 of 5
- ✓Profitable in the newest year$128 MNet income $128 M in fiscal 2025.
- ✗Profitable in each of the last five years2 of 5Profitable in 2 of the five years to fiscal 2025.
- ✗Operating margin above its peers' median4.5%4.5% against FMCG's median of 5.3% (40 companies).
- ✓Return on equity above 15%25.2%25.2% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- ✓Operating margin wider than three years earlier4.5%4.5% in fiscal 2025 against -13.0% in 2022.
Financial health3 of 3
- ✓Short-term assets cover short-term liabilities1.9×Current ratio 1.90 at the end of fiscal 2025.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2025.
- ✓Altman Z-score outside the distress zone3.97Z-score 3.97 (safe zone) for fiscal 2025.
Shareholder returns0 of 3
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year9.1%Diluted shares up 9.1% in fiscal 2025.
- ✗Dividends and buybacks above 3% of the market value1.3%Dividends and buybacks were 1.3% of the market value.
- ✗Free cash flow covers dividends and buybacks$57 MFree cash flow $57 M against $90 M paid out in fiscal 2025.
Worked out from the statements as filed (sec), the medians of FMCG, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from Hims & Hers Health, Inc.'s statements, beside the median of FMCG.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | 4.5% | 5.3% | |
| Net margin | 5.5% | 4.1% | |
| Return on equity | 25.2% | 11.2% | |
| Revenue growth, 3 years a year | 64.6% | 0.4% | |
| Revenue growth | 59.0% | 1.4% | |
| Free cash flow margin | 2.5% | 6.0% |
4of 8on the Piotroski tests of financial strength
- The share count rose 9.1% in the year.
- Receivables grew 426% while revenue grew 59%: customers are paying later, or sales were booked ahead of cash.
- Revenue has grown 6 years in a row.
Hims & Hers Health, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 | FY 2019to Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 2,348+59.0%100% | 1,477+69.3%100% | 872+65.5%100% | 527+93.8%100% | 272+82.8%100% | 149+80.2%100% | 83—100% | |
| Cost of revenue | 614+102%26.2% | 303+93.2%20.5% | 157+32.9%18.0% | 118+75.4%22.4% | 67+71.4%24.8% | 39+3.6%26.4% | 38—46.0% | |
| Gross profit | 1,733+47.8%73.8% | 1,173+64.1%79.5% | 715+74.9%82.0% | 409+99.9%77.6% | 204+86.8%75.2% | 109+145%73.6% | 45—54.0% | |
| Selling, general and administrative | — | — | — | — | 184+180%67.5% | 66+17.4%44.1% | 56—67.7% | |
| General and administrative | 273+62.6%11.6% | 168+29.2%11.4% | 130+32.3%14.9% | 98−13.6%18.6% | 114+337%41.8% | 26r4.8—17.5% | — | |
| Operating expenses | 1,628+46.5%69.3% | 1,111+49.3%75.3% | 744+55.9%85.4% | 477+49.4%90.6% | 320+156%118% | 125+4.7%83.8% | 119—144% | |
| Operating income | 106+70.6%4.5% | 62—4.2% | −29—−3.4% | −69—−13.0% | −115—−42.3% | −15r−4.8—−10.2% | −74—−90.1% | |
| Interest and finance income | — | — | — | — | — | 3.0—2.0% | — | |
| Interest expense and finance costs | — | — | — | — | 0−100%0.0% | 0.0−97.3%0.0% | 0.4—0.4% | |
| Other non-operating income (expense) | 18+86.7%0.8% | 9.8+24.4%0.7% | 7.9+164%0.9% | 3.0−29.6%0.6% | 4.2—1.6% | −2.8r1.7−217%−1.9% | 2.4—3.0% | |
| Income before tax | 124+72.8%5.3% | 72—4.9% | −22—−2.5% | −66—−12.5% | −111—−40.8% | −18—−12.1% | −72—−87.2% | |
| Income tax | −4.4—−0.2% | −54−2851%−3.7% | 2.0—0.2% | −0.0—−0.0% | −3.1−2569%−1.2% | 0.1+41.1%0.1% | 0.1—0.1% | |
| Net income attributable to shareholders | 128+1.8%5.5% | 126—8.5% | −24—−2.7% | −66—−12.5% | −108—−39.6% | −18r−3.0—−12.2% | −72—−87.3% | |
| Earnings per share, basic | 0.57−1.7%— | 0.58—— | -0.11—— | -0.32—— | -0.58—— | -0.51—— | -2.07—— | |
| Earnings per share, diluted | 0.51−3.8%— | 0.53—— | -0.11—— | -0.32—— | -0.58—— | -0.51—— | -2.07—— | |
| Shares, weighted average (basic) | 225+4.2%— | 216+3.1%— | 209+2.4%— | 205+9.5%— | 187+428%— | 35+1.7%— | 35—— | |
| Shares, weighted average (diluted) | 258+9.0%— | 237+13.1%— | 209+2.4%— | 205+9.5%— | 187+428%— | 35+1.7%— | 35—— | |
| Balance sheet | ||||||||
| Cash and cash equivalents | 229+3.6%10.6% | 221+128%31.2% | 97r97+107%21.9% | 47−34.8%12.8% | 72+163%17.1% | 27r1.1+1710%23.0% | 1.5—0.7% | |
| Short-term investments | 349+338%16.2% | 80−35.9%11.3% | 124−6.4%28.2% | 133−24.3%36.3% | 175+141%41.7% | 73—61.4% | — | |
| Receivables | 32+426%1.5% | 6.1−9.0%0.9% | 6.7+71.8%1.5% | 3.9−4.9%1.1% | 4.1+273%1.0% | 1.1—0.9% | — | |
| Inventory | 80+24.4%3.7% | 64+187%9.1% | 22+4.2%5.1% | 22+59.0%5.9% | 14+283%3.2% | 3.5—3.0% | — | |
| Other current assets | 4.4+994%0.2% | 0.4r8.9−90.5%0.1% | 4.2r5.2+135%1.0% | 1.8+101%0.5% | 0.9−54.7%0.2% | 2.0r0.2—1.7% | — | |
| Current assets | 768+93.9%35.6% | 396+49.3%55.9% | 265+22.4%60.1% | 217−19.8%59.1% | 270+139%64.2% | 113r1.1+6721%95.3% | 1.7—0.8% | |
| Property, plant and equipment | — | — | — | 3.0+36.4%0.8% | 2.2+29.4%0.5% | 1.7—1.4% | — | |
| Right-of-use (leased) assets | 137+1159%6.4% | 11+13.5%1.5% | 9.6+94.2%2.2% | 4.9−3.4%1.3% | 5.1—1.2% | 0—0.0% | — | |
| Goodwill | 278+147%12.9% | 113+1.7%15.9% | 1110.0%25.1% | 1110.0%30.3% | 111—26.4% | 0—0.0% | — | |
| Other intangible assets | 196+352%9.1% | 43+134%6.1% | 19−15.0%4.2% | 22−15.6%6.0% | 26+43781%6.2% | 0.1—0.0% | — | |
| Long-term investments | — | 0—0.0% | — | — | — | — | — | |
| Total assets | 2,155+205%100% | 708+60.4%100% | 441+20.4%100% | 366−12.9%100% | 421+254%100% | 119r206−42.0%100% | 205—100% | |
| Accounts payable | 143+57.1%6.6% | 91+112%12.9% | 43+33.1%9.8% | 32+64.8%8.8% | 20+143%4.7% | 8.1r0.0+43559%6.8% | 0.0—0.0% | |
| Current liabilities | 404+82.7%18.8% | 221+150%31.3% | 88+84.5%20.1% | 48−39.5%13.1% | 79+420%18.8% | 15r4.9+1455%12.8% | 1.0—0.5% | |
| Lease liabilities (non-current) | 143+1414%6.6% | 9.5+9.1%1.3% | 8.7+138%2.0% | 3.6−11.4%1.0% | 4.1—1.0% | 0—0.0% | — | |
| Total liabilities | 1,614+599%74.9% | 231+138%32.6% | 97+77.9%22.0% | 55−36.5%14.9% | 86+451%20.4% | 16r12+91.0%13.2% | 8.2—4.0% | |
| Retained earnings | −114—−5.3% | −242—−34.2% | −368—−83.5% | −345—−94.1% | −279—−66.3% | −171r−1.9−15031%−144% | 1.1—0.6% | |
| Shareholders' equity | 541+13.5%25.1% | 477+38.6%67.4% | 344+10.4%78.0% | 312−6.8%85.1% | 335—79.6% | −147r5.0—−124% | −140r5.0—−68.3% | |
| Total liabilities and equity | 2,155+205%100% | 708+60.4%100% | 441+20.4%100% | 366−12.9%100% | 421+254%100% | 119r206−42.0%100% | 205—100% | |
| Cash-flow statement | ||||||||
| Depreciation and amortization | 55+219%2.3% | 17+79.6%1.2% | 9.5+27.3%1.1% | 7.5+83.4%1.4% | 4.1+286%1.5% | 1.1+307%0.7% | 0.3—0.3% | |
| Share-based compensation | 135+46.5%5.8% | 92+39.7%6.3% | 66+54.3%7.6% | 43−36.3%8.1% | 67+1053%24.7% | 5.8−27.4%3.9% | 8.0—9.7% | |
| Cash from operating activities | 300+19.5%12.8% | 251+242%17.0% | 73—8.4% | −27—−5.0% | −34—−12.7% | −2.5r−0.8—−1.7% | −75—−90.7% | |
| Capital expenditure | −243—−10.3% | −53—−3.6% | −27—−3.0% | −7.2—−1.4% | — | — | — | |
| Acquisitions, net of cash acquired | −145—−6.2% | −15—−1.0% | 0—0.0% | 0—0.0% | −46—−17.1% | 0—0.0% | 0—0.0% | |
| Cash from investing activities | −1,025—−43.7% | −19—−1.3% | −12−135%−1.4% | 35—6.6% | −156—−57.5% | −40r0.3—−26.7% | −39—−47.6% | |
| Debt issued | — | — | — | — | 0—0.0% | 0−100%0.0% | 2.1—2.6% | |
| Debt repaid | — | — | — | 0—0.0% | 0—0.0% | −1.5—−1.0% | −9.1—−11.0% | |
| Shares bought back | −90—−3.8% | −83—−5.6% | −2.0—−0.2% | 0—0.0% | 0r−22—0.0% | 0—0.0% | 0—0.0% | |
| Cash from financing activities | 730—31.1% | −108—−7.3% | −11—−1.3% | −33−114%−6.3% | 235+392%86.5% | 48−49.9%32.1% | 95—115% | |
| Exchange-rate effect on cash | 2.5—0.1% | −0.3—−0.0% | −0.0—−0.0% | −0.1—−0.0% | −0.1—−0.0% | −0.0—−0.0% | −0.0—−0.0% | |
| Change in cash | 7.2−94.2%0.3% | 124+148%8.4% | 50—5.7% | −25−156%−4.7% | 44+698%16.3% | 5.6—3.7% | −19—−22.8% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q3 FY2026to Sep 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 2,870+29.8%100% | 890+48.6%100% | 753+38.2%100% | 608+3.8%100% | 618*+28.4%100% | 599+49.2%100% | 545+72.6%100% | 586+111%100% | 481*+95.1%100% | 402—100% | 316—100% | 278—100% | 247*—100% | |
| Cost of revenue | 1,038+87.9%36.2% | 381+143%42.8% | 272+112%36.2% | 211+36.1%34.8% | 173*+55.4%28.1% | 157+87.5%26.2% | 129+118%23.6% | 155+216%26.5% | 112*+162%23.2% | 84—20.8% | 59—18.7% | 49—17.6% | 43*—17.3% | |
| Gross profit | 1,831+10.4%63.8% | 509+15.2%57.2% | 481+15.5%63.8% | 397−7.9%65.2% | 444*+20.3%71.9% | 442+39.1%73.8% | 416+62.2%76.4% | 431+88.0%73.5% | 370*+81.1%76.8% | 318—79.2% | 257—81.3% | 229—82.4% | 204*—82.7% | |
| General and administrative | 503+106%17.5% | 151+87.8%17.0% | 165+146%22.0% | 110+126%18.0% | 76*+58.6%12.3% | 81+80.8%13.5% | 67+65.9%12.3% | 49+40.6%8.3% | 48*+48.6%10.0% | 45—11.1% | 41—12.8% | 35—12.4% | 32*—13.1% | |
| Operating expenses | 2,064+33.7%71.9% | 575+33.7%64.6% | 578+48.4%76.7% | 475+27.4%78.1% | 435*+24.0%70.4% | 430+45.6%71.8% | 389+58.6%71.5% | 373+70.1%63.6% | 351*+71.6%72.9% | 296—73.6% | 246—77.8% | 219—78.8% | 204*—82.9% | |
| Operating income | −232−302%−8.1% | −66−660%−7.4% | −97−464%−12.9% | −78−235%−12.9% | 9.2*−50.6%1.5% | 12−47.2%2.0% | 27+142%4.9% | 58+485%9.9% | 19*—3.9% | 22—5.6% | 11—3.5% | 9.9—3.6% | −0.4*—−0.2% | |
| Other non-operating income (expense) | 10−19.0%0.4% | 20+4683%2.2% | 4.6−25.6%0.6% | −23−994%−3.8% | 9.2*+148%1.5% | 0.4−65.9%0.1% | 6.1+156%1.1% | 2.6+3.9%0.4% | 3.7*+42.3%0.8% | 1.2—0.3% | 2.4—0.8% | 2.5—0.9% | 2.6*—1.1% | |
| Income before tax | −222−274%−7.7% | −46−478%−5.2% | −93−382%−12.3% | −102−268%−16.7% | 18*−17.7%3.0% | 12−48.2%2.0% | 33+145%6.0% | 60+388%10.3% | 22*+915%4.6% | 24—5.9% | 13—4.3% | 12—4.5% | 2.2*—0.9% | |
| Income tax | −31—−1.1% | −13—−1.5% | −6.3—−0.8% | −9.4−186%−1.6% | −2.2*—−0.4% | −3.6—−0.6% | −9.7−7700%−1.8% | 11+764%1.9% | −3.7*−493%−0.8% | −52—−12.9% | 0.1—0.0% | 1.3—0.5% | 1.0*—0.4% | |
| Net income attributable to shareholders | −191−243%−6.7% | −33−309%−3.7% | −86−303%−11.5% | −92−286%−15.1% | 21*−20.8%3.3% | 16−79.1%2.6% | 43+220%7.8% | 49+345%8.4% | 26*+1990%5.4% | 76—18.8% | 13—4.2% | 11—4.0% | 1.2*—0.5% | |
| Earnings per share, basic | — | -0.14−300%— | -0.37−295%— | -0.40−282%— | — | 0.07−80.0%— | 0.19+217%— | 0.22+340%— | — | 0.35—— | 0.06—— | 0.05—— | — | |
| Earnings per share, diluted | — | -0.14−333%— | -0.37−318%— | -0.40−300%— | — | 0.06−81.3%— | 0.17+183%— | 0.20+300%— | — | 0.32—— | 0.06—— | 0.05—— | — | |
| Shares, weighted average (basic) | 234+3.3%— | 234+3.3%— | 232+3.3%— | 228+2.9%— | — | 226+4.5%— | 224+4.5%— | 222+4.0%— | — | 217—— | 215—— | 213—— | — | |
| Shares, weighted average (diluted) | 234−6.0%— | 234−6.0%— | 232−9.7%— | 228−7.4%— | — | 249+5.8%— | 257+9.4%— | 247+7.5%— | — | 235—— | 235—— | 229—— | — | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 606—17.1% | 606+75.1%17.1% | 610−45.8%16.8% | 222−18.8%9.8% | 229+3.6%10.6% | 346+109%15.5% | 1,125+770%59.9% | 274+160%30.7% | 221+128%31.2% | 166—27.5% | 129—26.9% | 105—23.5% | 97r97—21.9% | |
| Short-term investments | 107—3.0% | 107−62.5%3.0% | 231+1054%6.4% | 529+980%23.3% | 349+338%16.2% | 284+221%12.7% | 20−79.6%1.1% | 49−50.2%5.5% | 80−35.9%11.3% | 89—14.7% | 98—20.4% | 98—21.9% | 124—28.2% | |
| Receivables | 428—12.1% | 428—12.1% | 375—10.3% | 150—6.6% | 32+426%1.5% | — | — | — | 6.1−9.0%0.9% | — | — | — | 6.7—1.5% | |
| Inventory | 108—3.0% | 108+1.8%3.0% | 88−38.1%2.4% | 79+3.9%3.5% | 80+24.4%3.7% | 106+116%4.7% | 142+249%7.6% | 76+155%8.5% | 64+187%9.1% | 49—8.2% | 41—8.4% | 30—6.7% | 22—5.1% | |
| Other current assets | 23—0.6% | 23−34.8%0.6% | 12−43.1%0.3% | 11−12.8%0.5% | 4.4+994%0.2% | 35+505%1.5% | 21+524%1.1% | 12+78.1%1.4% | 0.4r8.9−90.5%0.1% | 5.7—0.9% | 3.3—0.7% | 6.8—1.5% | 4.2r5.2—1.0% | |
| Current assets | 1,321—37.2% | 1,321+56.3%37.2% | 1,385+2.1%38.2% | 1,045+134%46.1% | 768+93.9%35.6% | 845+159%37.8% | 1,356+366%72.2% | 447+70.8%50.1% | 396+49.3%55.9% | 326—54.2% | 291—60.5% | 262—58.4% | 265—60.1% | |
| Right-of-use (leased) assets | 177—5.0% | 177+27.0%5.0% | 166+131%4.6% | 144+132%6.4% | 137+1159%6.4% | 139+1180%6.2% | 72+549%3.8% | 62+445%7.0% | 11+13.5%1.5% | 11—1.8% | 11—2.3% | 11—2.5% | 9.6—2.2% | |
| Goodwill | 1,111—31.3% | 1,111+328%31.3% | 1,102+836%30.4% | 343+191%15.1% | 278+147%12.9% | 259+130%11.6% | 118+6.2%6.3% | 118+6.2%13.2% | 113+1.7%15.9% | 113—18.7% | 111—23.1% | 111—24.7% | 111—25.1% | |
| Other intangible assets | 397—11.2% | 397+104%11.2% | 423+940%11.7% | 261+501%11.5% | 196+352%9.1% | 195+335%8.7% | 41+137%2.2% | 43+143%4.9% | 43+134%6.1% | 45—7.4% | 17—3.6% | 18—4.0% | 19—4.2% | |
| Long-term investments | — | — | — | — | — | 438—19.6% | — | — | 0—0.0% | — | — | — | — | |
| Total assets | 3,547—100% | 3,547+58.8%100% | 3,629+93.3%100% | 2,267+154%100% | 2,155+205%100% | 2,233+271%100% | 1,878+291%100% | 892+99.0%100% | 708+60.4%100% | 602—100% | 481—100% | 448—100% | 441—100% | |
| Accounts payable | 516—14.5% | 516+160%14.5% | 501+377%13.8% | 307+182%13.5% | 143+57.1%6.6% | 198+163%8.9% | 105+83.9%5.6% | 109+148%12.2% | 91+112%12.9% | 75—12.5% | 57—11.9% | 44—9.8% | 43—9.8% | |
| Current liabilities | 1,436—40.5% | 1,436+219%40.5% | 1,483+445%40.9% | 619+121%27.3% | 404+82.7%18.8% | 451+195%20.2% | 272+151%14.5% | 280+200%31.4% | 221+150%31.3% | 153—25.3% | 109—22.6% | 93—20.8% | 88—20.1% | |
| Lease liabilities (non-current) | 183—5.1% | 183+27.1%5.1% | 169+136%4.7% | 152+155%6.7% | 143+1414%6.6% | 144+1401%6.4% | 72+629%3.8% | 60+480%6.7% | 9.5+9.1%1.3% | 9.6—1.6% | 9.8—2.0% | 10—2.3% | 8.7—2.0% | |
| Total liabilities | 3,192—90.0% | 3,192+93.2%90.0% | 3,305+151%91.1% | 1,821+432%80.3% | 1,614+599%74.9% | 1,652+919%74.0% | 1,315+1009%70.0% | 342+230%38.4% | 231+138%32.6% | 162—26.9% | 119—24.7% | 104—23.1% | 97—22.0% | |
| Retained earnings | −325—−9.2% | −325—−9.2% | −292—−8.1% | −206—−9.1% | −114—−5.3% | −134—−6.0% | −150—−8.0% | −193—−21.6% | −242—−34.2% | −268—−44.5% | −344—−71.5% | −357—−79.7% | −368—−83.5% | |
| Shareholders' equity | 355—10.0% | 355−38.8%10.0% | 324−42.4%8.9% | 446−18.8%19.7% | 541+13.5%25.1% | 581+32.0%26.0% | 563+55.5%30.0% | 549+59.4%61.6% | 477+38.6%67.4% | 440—73.1% | 362—75.3% | 344—76.9% | 344—78.0% | |
| Total liabilities and equity | 3,547—100% | 3,547+58.8%100% | 3,629+93.3%100% | 2,267+154%100% | 2,155+205%100% | 2,233+271%100% | 1,878+291%100% | 892+99.0%100% | 708+60.4%100% | 602—100% | 481—100% | 448—100% | 441—100% | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | 108+154%3.8% | 38*+116%4.3% | 29*+182%3.9% | 22+165%3.6% | 18*+198%2.9% | 18*+303%2.9% | 10*+187%1.9% | 8.3+176%1.4% | 6.1*+128%1.3% | 4.4*—1.1% | 3.6*—1.2% | 3.0—1.1% | 2.7*—1.1% | |
| Share-based compensation | 178+42.2%6.2% | 64+60.5%7.2% | 42+17.9%5.6% | 37+48.3%6.1% | 34*+41.6%5.6% | 40+61.3%6.7% | 36+48.6%6.6% | 25+30.6%4.2% | 24*+36.9%5.1% | 25—6.2% | 24—7.6% | 19—6.8% | 18*—7.2% | |
| Cash from operating activities | 180−44.6%6.3% | 65*−56.0%7.3% | −36*—−4.8% | 89−18.1%14.7% | 61*−29.0%9.9% | 149*+74.4%24.8% | −19*−136%−3.5% | 109+322%18.6% | 86*+293%18.0% | 85*—21.2% | 54*—17.0% | 26—9.3% | 22*—8.9% | |
| Capital expenditure | −172—−6.0% | −39—−4.4% | −32—−4.3% | −36—−6.0% | −64*—−10.3% | −69r−69—−11.6% | −50—−9.3% | −59—−10.1% | −27*—−5.6% | −5.9—−1.5% | −6.0—−1.9% | −14—−5.0% | — | |
| Acquisitions, net of cash acquired | −342—−11.9% | 0*—0.0% | −180*—−23.9% | −138—−22.7% | −23*—−3.8% | −117*—−19.5% | 0*—0.0% | −5.1—−0.9% | 0*—0.0% | −15*—−3.8% | 0*—0.0% | 0—0.0% | 0*—0.0% | |
| Cash from investing activities | −70—−2.4% | −55*—−6.2% | 85*—11.2% | −15—−2.5% | −84*—−13.5% | −887*—−148% | −21*—−3.9% | −33−351%−5.6% | −17*−183%−3.6% | −10*—−2.6% | −4.5*—−1.4% | 13—4.7% | 21*—8.4% | |
| Shares bought back | — | — | — | — | −80*—−13.0% | −9.5*—−1.6% | 0*—0.0% | 0—0.0% | −5.0*—−1.0% | −30*—−7.5% | −20*—−6.3% | −28—−10.1% | −2.0*—−0.8% | |
| Cash from financing activities | 147−81.9%5.1% | −19*—−2.1% | 342*−61.6%45.4% | −78—−12.8% | −98*—−15.8% | −39*—−6.5% | 889*—163% | −23—−3.9% | −14*—−2.8% | −39*—−9.7% | −25*—−7.9% | −30—−10.9% | −4.0*—−1.6% | |
| Exchange-rate effect on cash | 2.3—0.1% | 4.7*—0.5% | −2.8*−374%−0.4% | −2.4−1079%−0.4% | 2.7*—0.4% | −1.5*−882%−0.2% | 1.0*—0.2% | 0.2+12050%0.0% | −0.5*—−0.1% | 0.2*—0.0% | −0.0*—−0.0% | 0.0—0.0% | −0.0*—−0.0% | |
| Change in cash | 260+44.8%9.1% | −4.2*—−0.5% | 388*−54.4%51.5% | −6.4−112%−1.0% | −117*−313%−19.0% | −779*−2251%−130% | 850*+3433%156% | 54+524%9.1% | 55*+42.4%11.4% | 36*—9.0% | 24*—7.6% | 8.6—3.1% | 39*—15.7% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What Hims & Hers Health, Inc. sells: revenue by product line, fiscal 2025#
As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.
Countries and regions
- 🇺🇸 USA$2.2 B94%+53%
- Rest of the World Revenue(total)$134 M5.7%+399%
Source: SEC annual report (XBRL data) · as of Dec 31, 2025
Where Hims & Hers Health, Inc. operates: 6 countries#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 17 subsidiaries on file.
| Country | Presence | Revenue there |
|---|---|---|
| 🇺🇸 USA | Headquarters1 office10 subsidiaries | $2.2 B94% |
| 🇩🇪 Germany | 3 subsidiaries | — |
| 🇬🇧 UK | 2 subsidiaries | — |
| 🇨🇦 Canada | 1 subsidiary | — |
| 🇮🇪 Ireland | 1 subsidiary | — |
| 🇰🇾 Cayman Islands | 1 office | — |
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file; map outlines from Natural Earth. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
Executive pay at Hims & Hers Health, Inc.#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2025Andrew Dudum | $23.0 M | $159.7 M | $17.5 M | $210 (peers $113) |
| 2024Andrew Dudum | $24.6 M | $110.3 M | $7.2 M | $157 (peers $98) |
| 2023Andrew Dudum | $14.4 M | $21.4 M | $6.5 M | $58 (peers $76) |
| 2022Andrew Dudum | $10.8 M | $10.7 M | $5.0 M | $42 (peers $47) |
| 2021Andrew Dudum | $15.2 M | $26.8 M | $3.3 M | $42 (peers $90) |
Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025
Events at Hims & Hers Health, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.
Directors and officers 6 · Material agreement 6 · New debt 4 · Unregistered share sale 3 · Shareholder vote 2 · Results announced 9
| Filed | What happened | Filing |
|---|---|---|
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Material agreementNew debt | 8-K | |
| Shareholder vote | 8-K | |
| Material agreementNew debt | 8-K | |
| Material agreementNew debtUnregistered share sale | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Material agreement | 8-K | |
| Results announced | 8-K | |
| Shareholder vote | 8-K | |
| Material agreementNew debtUnregistered share sale | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 9, 2026
Acquisitions and funding#
5 acquisitions, $322 M paid where reported
Businesses it acquired
| Acquired | Acquisition date | Completion | Price | Stake | Source |
|---|---|---|---|---|---|
| Eucalyptus HealthDigital Health Company | 2025 | — | — | — | Wikidata |
| Zava Global GmbH | 2025 | — | $258 M | — | Annual report |
| Medici Technologies, Inc dba Livewell | 2025 | — | $28 M | — | Annual report |
| Sigmund NJ, LLC, Trybe Labs | 2025 | — | $5 M | — | Annual report |
| Seaview Enterprises LLC, MedisourceRx | 2024 | — | $31 M | — | Annual report |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
Lobbying by Hims & Hers Health, Inc.#
$1.4 M spent on lobbying the US Congress and federal agencies in 2025, most often on health issues and pharmacy.
- Health Issues10 reports
- Pharmacy1 report
Lobbying firms hired in 2025
Kountoupes Denham Carr & Reid, LLC $240 K · Cassidy & Associates, Inc. $60 K
The firms' fees are part of Hims & Hers Health, Inc.'s own reported expenses, so they are not added again.
| Year | Spending | Own lobbyists | Reports |
|---|---|---|---|
| 2026 (so far) | $920 K | $920 K | 9 |
| 2025 | $1.4 M | $1.4 M | 10 |
| 2024 | $220 K | — | 3 |
| 2023 | $20 K | — | 1 |
Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “Hims & Hers Health, Inc.”, “HIMS & HERS HEALTH, INC.” and “Hims & Hers Health, Inc. (formerly Hims, Inc)”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero
Discuss Hims & Hers Health, Inc.#
3 automatic updates and 0 member comments. Sign in to comment and react.
- Results announced on 9 November 2026automatic update · Nov 9, 2026
Hims & Hers Health, Inc. announced results on 9 November 2026 (SEC Form 8-K, item 2.02). For the quarter ended 30 September 2026: revenue of $890 million (up 49% from a year earlier) and a net loss of $33 million.
- Insider trading in October 2026automatic update · Oct 31, 2026
Directors and officers of Hims & Hers Health, Inc. reported open-market trades for October 2026 (SEC Forms 4 and 5): 2 insiders sold shares worth about $255,528 in 3 trades. Awards, option exercises and shares withheld for tax are not counted.
- Mutual funds: 247 funds hold $2.1 billionautomatic update · Jul 31, 2026
247 mutual funds in 2 countries hold shares of Hims & Hers Health, Inc. worth $2.1 billion, about 27.1% of the company (funds' newest reports, up to 31 July 2026). Since their previous reports 151 funds added shares and 84 sold; on balance they bought $146 million. Share splits are not counted as trading.
How Hims & Hers Health, Inc. compares in FMCG
- Market cap$7.0 B · higher than 81% of 110
- Revenue$2.3 B · higher than 69% of 104
- Net margin-6.7% · higher than 11% of 103
- Revenue growth59.0% · highest of 46
- Price / sales2.4× · lower than 37% of 72
- Price / book12.9× · lower than 11% of 71
- FCF yield0.8% · higher than 24% of 34
Peer comparison · FMCG
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Hims & Hers Health, Inc.🇺🇸 | $7.0 B | — | -6.7% | +59.0% |
| The Procter & Gamble Company🇺🇸 | $372.2 B | 23.2× | 18.2% | +3.3% |
| L'Oréal S.A.🇫🇷 | $241.7 B | 33.3× | 13.9% | +5.5% |
| Unilever PLC🇬🇧 | $135.7 B | 12.7× | 18.8% | +0.3% |
| Colgate-Palmolive Company🇺🇸 | $74.8 B | 36.4× | 9.7% | +1.4% |
| Hindustan Unilever Limited🇮🇳 | $52.2 B | 32.2× | 23.6% | — |
| Reckitt Benckiser Group PLC🇬🇧 | $44.3 B | 10.2× | 22.4% | +3.3% |
| Haleon plc🇬🇧 | $42.6 B | 19.4× | 15.1% | +1.2% |
| The Estée Lauder Companies Inc.🇺🇸 | $39.6 B | 107.6× | 2.4% | +5.0% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Kimberly-Clark de México, S. A. B. de C. V.$6.9 B
- e.l.f. Beauty, Inc.$6.8 B
- Amorepacific Corporation$6.7 B
- Dabur India Limited$7.4 B
- Cupid Limited$5.3 B
- Shiseido Company, Limited$9.3 B
Sources and freshness
- Market cap:
- Oct 30, 2026
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Employees:
- As on 2021
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research, Wikidata, Wikipedia, GLEIF register; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Hims & Hers Health, Inc.? Verify and update this profile — free
Show Hims & Hers Health, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.